These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 37751026)

  • 61. PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study.
    Summers KL; Dolgova NV; Gagnon KB; Sopasis GJ; James AK; Lai B; Sylvain NJ; Harris HH; Nichol HK; George GN; Pickering IJ
    Metallomics; 2020 Dec; 12(12):1979-1994. PubMed ID: 33169753
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biochemical pathways of copper complexes: progress over the past 5 years.
    Zehra S; Tabassum S; Arjmand F
    Drug Discov Today; 2021 Apr; 26(4):1086-1096. PubMed ID: 33486113
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Current and Future of "Turn-On" Based Small-Molecule Copper Probes for Cuproptosis.
    Peng TE; Qiu F; Qu Y; Yu C; Cheng X; Li L
    ChemistryOpen; 2023 Sep; 12(9):e202300078. PubMed ID: 37705070
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Copper in cancer: From pathogenesis to therapy.
    Guan D; Zhao L; Shi X; Ma X; Chen Z
    Biomed Pharmacother; 2023 Jul; 163():114791. PubMed ID: 37105071
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Copper compounds in cancer chemotherapy.
    Ruiz-Azuara L; Bravo-Gómez ME
    Curr Med Chem; 2010; 17(31):3606-15. PubMed ID: 20846116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis.
    Li H; Jiang H; Huang Z; Chen Z; Chen N
    Aging (Albany NY); 2023 Aug; 15(16):8325-8344. PubMed ID: 37616061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabolism and functions of copper in brain.
    Scheiber IF; Mercer JF; Dringen R
    Prog Neurobiol; 2014 May; 116():33-57. PubMed ID: 24440710
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potential of Copper and Copper Compounds for Anticancer Applications.
    Ji P; Wang P; Chen H; Xu Y; Ge J; Tian Z; Yan Z
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259382
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Copper signaling in the brain and beyond.
    Ackerman CM; Chang CJ
    J Biol Chem; 2018 Mar; 293(13):4628-4635. PubMed ID: 29084848
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Copper and angiogenesis: unravelling a relationship key to cancer progression.
    Finney L; Vogt S; Fukai T; Glesne D
    Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):88-94. PubMed ID: 18505439
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
    Liu H; Tang T
    Front Oncol; 2022; 12():952290. PubMed ID: 36276096
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.
    Milanino R; Conforti A; Franco L; Marrella M; Velo G
    Agents Actions; 1985 Sep; 16(6):504-13. PubMed ID: 3907313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Copper Depletion as a Therapeutic Strategy in Cancer.
    Lopez J; Ramchandani D; Vahdat L
    Met Ions Life Sci; 2019 Jan; 19():. PubMed ID: 30855113
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Copper-instigated modulatory cell mortality mechanisms and progress in oncological treatment investigations.
    Gao L; Zhang A
    Front Immunol; 2023; 14():1236063. PubMed ID: 37600774
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Zinc and Copper Homeostasis in Head and Neck Cancer: Review and Meta-Analysis.
    Ressnerova A; Raudenska M; Holubova M; Svobodova M; Polanska H; Babula P; Masarik M; Gumulec J
    Curr Med Chem; 2016; 23(13):1304-30. PubMed ID: 27048341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer.
    Yang X; Deng L; Diao X; Yang S; Zou L; Yang Q; Li J; Nie J; Zhao L; Jiao B
    iScience; 2023 Nov; 26(11):108218. PubMed ID: 37953954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
    Liu C; Wu S; Lai L; Liu J; Guo Z; Ye Z; Chen X
    BMC Bioinformatics; 2023 Jan; 24(1):4. PubMed ID: 36597032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.